Advances and ongoing challenges in eosinophilic gastrointestinal disorders presented at the CEGIR/TIGERs Symposium at the 2024 American Academy of Allergy, Asthma & Immunology meeting
Benjamin L Wright,Juan Pablo Abonia,Edsel M Abud,Seema S Aceves,Steven J Ackerman,Melinda Braskett,Joy W Chang,Mirna Chehade,Gregory M Constantine,Carla M Davis,Evan S Dellon,Alfred D Doyle,Raquel Durban,David A Hill,Elizabeth T Jensen,Anupama Kewalramani,Paneez Khoury,Amy D Klion,Leah Kottyan,Fei Li Kuang,Emily C McGowan,Melanie A Ruffner,Lisa A Spencer,Jonathan M Spergel,Amiko M Uchida,Joshua B Wechsler,Robert D Pesek
DOI: https://doi.org/10.1016/j.jaci.2024.07.022
2024-08-05
Abstract:The Consortium of Eosinophilic Gastrointestinal disease Researchers (CEGIR) and The International Gastrointestinal Eosinophil Researchers (TIGERs) organized a daylong symposium at the 2024 annual meeting of the American Academy of Allergy, Asthma & Immunology. The symposium featured new discoveries in basic and translational research as well as debates on the mechanisms and management of eosinophilic gastrointestinal diseases. Updates on recent clinical trials and consensus guidelines were also presented. We summarize the updates on eosinophilic gastrointestinal diseases presented at the symposium.